NBE Therapeutics (Switzerland)

Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency

Roger R. Beerli, Tamara Hell, Anna S. Merkel et al. · PLoS ONE · 2015 · 213 citations · Full text

Synthetic Immunology, Medicinal Chemistry, Vivo Potency +17

A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer

Lucia D’Amico, Ulrike Menzel, Michael Prummer et al. · Journal for ImmunoTherapy of Cancer · 2019 · 116 citations · Full text

Breast Oncology, Pd-1 Blockade, Adaptive Immune System +17

Highly Potent, Anthracycline-based Antibody–Drug Conjugates Generated by Enzymatic, Site-specific Conjugation

Nikolas Stefan, Rémy Gébleux, Lorenz Waldmeier et al. · Molecular Cancer Therapeutics · 2017 · 74 citations · Full text

Non-covalent SARS-CoV-2 Mpro inhibitors developed from in silico screen hits

Giacomo Rossetti, Marianna Ossorio, S. Rempel et al. · Scientific Reports · 2022 · 65 citations · Full text

Senescent cells perturb intestinal stem cell differentiation through Ptk7 induced noncanonical Wnt and YAP signaling

Jina Yun, Simon Hansen, Otto Morris et al. · Nature Communications · 2023 · 58 citations · Full text